Display options
Cite
Putcha P, Yu J, Rodriguez-Barrueco R, et al. Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers. Breast Cancer Res. 2017;19(1):49doi: 10.1186/s13058-017-0841-6.
Putcha, P., Yu, J., Rodriguez-Barrueco, R., Saucedo-Cuevas, L., Villagrasa, P., Murga-Penas, E., Quayle, S. N., Yang, M., Castro, V., Llobet-Navas, D., Birnbaum, D., Finetti, P., Woodward, W. A., Bertucci, F., Alpaugh, M. L., Califano, A., & Silva, J. (2017). Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers. Breast cancer research : BCR, 19(1), 49. https://doi.org/10.1186/s13058-017-0841-6
Putcha, Preeti, et al. "Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers." Breast cancer research : BCR vol. 19,1 (2017): 49. doi: https://doi.org/10.1186/s13058-017-0841-6
Putcha P, Yu J, Rodriguez-Barrueco R, Saucedo-Cuevas L, Villagrasa P, Murga-Penas E, Quayle SN, Yang M, Castro V, Llobet-Navas D, Birnbaum D, Finetti P, Woodward WA, Bertucci F, Alpaugh ML, Califano A, Silva J. Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers. Breast Cancer Res. 2017 Apr 19;19(1):49. doi: 10.1186/s13058-017-0841-6. PMID: 28424080; PMCID: PMC5397760.
Copy Download .nbib Format: NLM
Share it on

Breast Cancer Res. 2017 Apr 19;19(1):49. doi: 10.1186/s13058-017-0841-6.

Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers.

Breast cancer research : BCR

Preeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, Laura Saucedo-Cuevas, Patricia Villagrasa, Eva Murga-Penas, Steven N Quayle, Min Yang, Veronica Castro, David Llobet-Navas, Daniel Birnbaum, Pascal Finetti, Wendy A Woodward, François Bertucci, Mary L Alpaugh, Andrea Califano, Jose Silva

Affiliations

  1. Herbert Irving Comprehensive Cancer Center, Columbia University, 1130 St. Nicholas Avenue, New York, NY, 10032, USA.
  2. Department of Biomedical Informatics, Department of Systems Biology, Center for Computational Biology and Bioinformatics, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, 10032, USA.
  3. Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029-6574, USA.
  4. Department of Pathology, Columbia University Medical Center, 630 West168th Street, New York, NY, 10032, USA.
  5. Acetylon Pharmaceuticals, Inc., 70 Fargo St, Suite 205, Boston, MA, 02210, USA.
  6. Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
  7. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  8. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. [email protected].
  9. Department of Biomedical Informatics, Department of Systems Biology, Center for Computational Biology and Bioinformatics, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, 10032, USA. [email protected].
  10. Department of Biochemistry and Molecular Biophysics, Institute for Cancer Genetics, Columbia University, New York, NY, 10032, USA. [email protected].
  11. Herbert Irving Comprehensive Cancer Center, Columbia University, 1130 St. Nicholas Avenue, New York, NY, 10032, USA. [email protected].
  12. Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029-6574, USA. [email protected].

PMID: 28424080 PMCID: PMC5397760 DOI: 10.1186/s13058-017-0841-6

[No abstract available.]

References

  1. Breast Cancer Res. 2015 Dec 08;17(1):149 - PubMed

Publication Types

Grant support